JESSICA GALLAGHER: Open Payments
NPI 1124197793 · FAIRBORN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 28 payments from 9 companies in 2025. Trend: 2023 $410 · 2024 $681 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $304 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Lundbeck LLC | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Alkermes, Inc. | 2 | $31 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Luye Pharma (USA) Ltd. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: VRAYLAR, REXULTI, MAVYRET, CAPLYTA, Kerendia, Qelbree, ERZOFRI EXTENDED-RELEASE, COBENFY.
Industry payments across OH — which companies pay providers there.
